GMPC-Policy on Authorship

Authors imply responsibility and accountability for the published data. Authors must take all necessary steps to properly address any concerns regarding the accuracy and integrity of all parts of the manuscript. They must uphold the required ethical requirements according to the recognized standards.
Authorship: The Author is the individual who has to make a significant contribution to the work by incorporation in one or more of the following tasks: i) conceptualization and design of the study, ii) methodology, iii) data acquisition, iv) result analysis, or interpretation and v) achieving an important level of intellectual content by drafting, revising and approval of the article. The „Contributor Roles Taxonomy“ (CRediT Taxonomy) describes each author's contributions to the work. All authors must fulfill the authorship criteria. GMPC requests the authors to provide authorship order before submitting the article to avoid future conflicts. Authors are asked to provide an author contributorship statement to specify each author's work. Please refer to the International Committee of Medical Journal Editors (ICMJE) and COPE guidelines for more information about authorship.

• Acknowledgment: Individuals who didn't significantly incorporate in the research (Gift authors) should be removed from the authorship list and should be listed in the acknowledgment.
• Corresponding author: The research group should assign a corresponding author(s) to handle the manuscript, contact journals and editors, and to be responsible for correspondence during the submission and publication, including revising and approving the article proofs.
• Research ethics: Authors must follow the research ethics guidelines. Before doing research, authors should obtain approval from the Institutional Ethics Committee. Authors must provide a statement of approval from the Institutional Review Board (IRB) and, where applicable, informed consent. Clinical trials must be registered in any of the known clinical trial registries according to the national and international regulations. Please check GMPC ethical policy.
• Originality: Authors are asked to indicate whether the research work has been previously published or presented.
• Raw data: The raw data relevant to the manuscript may be requested from the authors for editorial assessment. They should be ready to make such data accessible to the general public.
• Conflict of interest: Authors must declare any conflict of interest.
• Change in authorship: All authors should approve any change of the authorship during the peer-review process or post-publication. Authorship change includes adding or removing the author(s) and/or re-arranging the order of authors' names. After acceptance, any request about the change in authorship after acceptance will also be evaluated by the GMPC editorial office.
• Consortium/Group authorship: Group authorship is recommended by the International Committee of Medical Journal Editors (ICMJE) when a large group has conducted the work. The group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the authorship criteria and complete the journal-specific author and conflict-of-interest disclosure forms. Funding, data collection, or general management of the study team alone do not qualify as authorship.
• Deceased Authors: The corresponding author or co-authors must notify the editorial office if a paper is submitted with a deceased author listed among the authors or if an author is deceased during the peer review process. If the corresponding author was deceased, the authors should choose an author for this role and communicate with the editorial office. The corresponding author must verify the deceased author's contribution and any potential conflicts of interest. A statement will be included under the deceased author list of the accepted papers. Please refer to COPE Case 19-09 for more information about the deceased author.

Last updated: 15-Feb-2023